{"success":true,"data":{"pressRelease":{"id":"19753","rtpr_id":"nPnby5pZga","ticker":"IBRX","exchange":"NASDAQ","all_tickers":["IBRX"],"title":"IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm","author":"PR Newswire","published_at":"2026-05-04T20:27:00.041Z","article_body":"IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm\n\nPR Newswire\n\nNEW YORK, May 4, 2026\n\nNEW YORK, May 4, 2026 /PRNewswire/ --\n\n(https://mma.prnewswire.com/media/2598258/THE_ROSEN_LAW_FIRM_P_A_Logo.html)\n\nWhy: Rosen Law Firm, a global investor rights law firm, reminds purchasers of\nsecurities of ImmunityBio, Inc. (NASDAQ: IBRX) between January 19, 2026 and\nMarch 24, 2026, both dates inclusive (the \"Class Period\"), of the important\nMay 26, 2026 lead plaintiff deadline in the securities class action first\nfiled by the Firm.\n\nSo What: If you purchased ImmunityBio securities during the Class Period you\nmay be entitled to compensation without payment of any out of pocket fees or\ncosts through a contingency fee arrangement.\n\nWhat to do next: To join the ImmunityBio class action, go to\nhttps://rosenlegal.com/submit-form/?case_id=17455\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4680027-1&h=2086350108&u=https%3A%2F%2Frosenlegal.com%2Fsubmit-form%2F%3Fcase_id%3D17455&a=https%3A%2F%2Frosenlegal.com%2Fsubmit-form%2F%3Fcase_id%3D17455)\nor call Phillip Kim, Esq. toll-free at 866-767-3653 or email\ncase@rosenlegal.com (mailto:case@rosenlegal.com) for information on the class\naction. A class action lawsuit has already been filed. If you wish to serve as\nlead plaintiff, you must move the Court no later than May 26, 2026. A lead\nplaintiff is a representative party acting on behalf of other class members in\ndirecting the litigation.\n\nWhy Rosen Law: We encourage investors to select qualified counsel with a track\nrecord of success in leadership roles. Often, firms issuing notices do not\nhave comparable experience, resources, or any meaningful peer recognition.\nMany of these firms do not actually handle securities class actions, but are\nmerely middlemen that refer clients or partner with law firms that actually\nlitigate the cases. Be wise in selecting counsel. The Rosen Law Firm\nrepresents investors throughout the globe, concentrating its practice in\nsecurities class actions and shareholder derivative litigation. Rosen Law Firm\nhas achieved, at that time, the largest ever securities class action\nsettlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS\nSecurities Class Action Services for number of securities class action\nsettlements in 2017. The firm has been ranked in the top 4 each year since\n2013 and has recovered hundreds of millions of dollars for investors. In 2019\nalone the firm secured over $438 million for investors. In 2020, founding\npartner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many\nof the firm's attorneys have been recognized by Lawdragon and Super Lawyers.\n\nDetails of the case: According to the lawsuit, defendants throughout the Class\nPeriod made false and/or misleading statements and/or failed to disclose that:\n(1) defendant Patrick Soon-Shiong materially overstated Anktiva's\ncapabilities; and (2) as a result, defendants' statements about ImmunityBio's\nbusiness, operations, and prospects were materially false and misleading\nand/or lacked a reasonable basis at all relevant times. When the true details\nentered the market, the lawsuit claims that investors suffered damages.\n\nTo join the ImmunityBio class action, go to\nhttps://rosenlegal.com/submit-form/?case_id=17455\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4680027-1&h=2086350108&u=https%3A%2F%2Frosenlegal.com%2Fsubmit-form%2F%3Fcase_id%3D17455&a=https%3A%2F%2Frosenlegal.com%2Fsubmit-form%2F%3Fcase_id%3D17455)\nor call Phillip Kim, Esq. toll-free at 866-767-3653 or email\ncase@rosenlegal.com (mailto:case@rosenlegal.com) for information on the class\naction.\n\nNo Class Has Been Certified. Until a class is certified, you are not\nrepresented by counsel unless you retain one. You may select counsel of your\nchoice. You may also remain an absent class member and do nothing at this\npoint. An investor's ability to share in any potential future recovery is not\ndependent upon serving as lead plaintiff.\n\nFollow us for updates on LinkedIn:\nhttps://www.linkedin.com/company/the-rosen-law-firm\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4680027-1&h=796664196&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fthe-rosen-law-firm&a=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fthe-rosen-law-firm)\nor on Twitter: https://twitter.com/rosen_firm\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4680027-1&h=353922000&u=https%3A%2F%2Ftwitter.com%2Frosen_firm&a=https%3A%2F%2Ftwitter.com%2Frosen_firm)\nor on Facebook: https://www.facebook.com/rosenlawfirm\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4680027-1&h=2979209596&u=https%3A%2F%2Fwww.facebook.com%2Frosenlawfirm&a=https%3A%2F%2Fwww.facebook.com%2Frosenlawfirm)\n.\n\nAttorney Advertising. Prior results do not guarantee a similar outcome.\n\nContact Information:\n\n     Laurence Rosen, Esq.\n     Phillip Kim, Esq.\n     The Rosen Law Firm, P.A.\n     275 Madison Avenue, 40(th) Floor\n     New York, NY 10016\n     Tel: (212) 686-1060\n     Toll Free: (866) 767-3653\n     Fax: (212) 202-3827\n     case@rosenlegal.com (mailto:case@rosenlegal.com)\n     www.rosenlegal.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4680027-1&h=2029784092&u=http%3A%2F%2Fwww.rosenlegal.com%2F&a=www.rosenlegal.com)\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-first-filed-by-the-rosen-law-firm-302761651.html\n(https://www.prnewswire.com/news-releases/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-first-filed-by-the-rosen-law-firm-302761651.html)\n\nSOURCE THE ROSEN LAW FIRM, P. A.\n\n\n\nPhoto: \nhttps://mma.prnewswire.com/media/2598258/THE_ROSEN_LAW_FIRM_P_A_Logo.jpg\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPnby5pZga","title":"IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm","author":"PR Newswire","ticker":"IBRX","created":"2026-05-04T20:27:00.041Z","tickers":["IBRX"],"exchange":"NASDAQ","article_body":"IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm\n\nPR Newswire\n\nNEW YORK, May 4, 2026\n\nNEW YORK, May 4, 2026 /PRNewswire/ --\n\n(https://mma.prnewswire.com/media/2598258/THE_ROSEN_LAW_FIRM_P_A_Logo.html)\n\nWhy: Rosen Law Firm, a global investor rights law firm, reminds purchasers of\nsecurities of ImmunityBio, Inc. (NASDAQ: IBRX) between January 19, 2026 and\nMarch 24, 2026, both dates inclusive (the \"Class Period\"), of the important\nMay 26, 2026 lead plaintiff deadline in the securities class action first\nfiled by the Firm.\n\nSo What: If you purchased ImmunityBio securities during the Class Period you\nmay be entitled to compensation without payment of any out of pocket fees or\ncosts through a contingency fee arrangement.\n\nWhat to do next: To join the ImmunityBio class action, go to\nhttps://rosenlegal.com/submit-form/?case_id=17455\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4680027-1&h=2086350108&u=https%3A%2F%2Frosenlegal.com%2Fsubmit-form%2F%3Fcase_id%3D17455&a=https%3A%2F%2Frosenlegal.com%2Fsubmit-form%2F%3Fcase_id%3D17455)\nor call Phillip Kim, Esq. toll-free at 866-767-3653 or email\ncase@rosenlegal.com (mailto:case@rosenlegal.com) for information on the class\naction. A class action lawsuit has already been filed. If you wish to serve as\nlead plaintiff, you must move the Court no later than May 26, 2026. A lead\nplaintiff is a representative party acting on behalf of other class members in\ndirecting the litigation.\n\nWhy Rosen Law: We encourage investors to select qualified counsel with a track\nrecord of success in leadership roles. Often, firms issuing notices do not\nhave comparable experience, resources, or any meaningful peer recognition.\nMany of these firms do not actually handle securities class actions, but are\nmerely middlemen that refer clients or partner with law firms that actually\nlitigate the cases. Be wise in selecting counsel. The Rosen Law Firm\nrepresents investors throughout the globe, concentrating its practice in\nsecurities class actions and shareholder derivative litigation. Rosen Law Firm\nhas achieved, at that time, the largest ever securities class action\nsettlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS\nSecurities Class Action Services for number of securities class action\nsettlements in 2017. The firm has been ranked in the top 4 each year since\n2013 and has recovered hundreds of millions of dollars for investors. In 2019\nalone the firm secured over $438 million for investors. In 2020, founding\npartner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many\nof the firm's attorneys have been recognized by Lawdragon and Super Lawyers.\n\nDetails of the case: According to the lawsuit, defendants throughout the Class\nPeriod made false and/or misleading statements and/or failed to disclose that:\n(1) defendant Patrick Soon-Shiong materially overstated Anktiva's\ncapabilities; and (2) as a result, defendants' statements about ImmunityBio's\nbusiness, operations, and prospects were materially false and misleading\nand/or lacked a reasonable basis at all relevant times. When the true details\nentered the market, the lawsuit claims that investors suffered damages.\n\nTo join the ImmunityBio class action, go to\nhttps://rosenlegal.com/submit-form/?case_id=17455\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4680027-1&h=2086350108&u=https%3A%2F%2Frosenlegal.com%2Fsubmit-form%2F%3Fcase_id%3D17455&a=https%3A%2F%2Frosenlegal.com%2Fsubmit-form%2F%3Fcase_id%3D17455)\nor call Phillip Kim, Esq. toll-free at 866-767-3653 or email\ncase@rosenlegal.com (mailto:case@rosenlegal.com) for information on the class\naction.\n\nNo Class Has Been Certified. Until a class is certified, you are not\nrepresented by counsel unless you retain one. You may select counsel of your\nchoice. You may also remain an absent class member and do nothing at this\npoint. An investor's ability to share in any potential future recovery is not\ndependent upon serving as lead plaintiff.\n\nFollow us for updates on LinkedIn:\nhttps://www.linkedin.com/company/the-rosen-law-firm\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4680027-1&h=796664196&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fthe-rosen-law-firm&a=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fthe-rosen-law-firm)\nor on Twitter: https://twitter.com/rosen_firm\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4680027-1&h=353922000&u=https%3A%2F%2Ftwitter.com%2Frosen_firm&a=https%3A%2F%2Ftwitter.com%2Frosen_firm)\nor on Facebook: https://www.facebook.com/rosenlawfirm\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4680027-1&h=2979209596&u=https%3A%2F%2Fwww.facebook.com%2Frosenlawfirm&a=https%3A%2F%2Fwww.facebook.com%2Frosenlawfirm)\n.\n\nAttorney Advertising. Prior results do not guarantee a similar outcome.\n\nContact Information:\n\n     Laurence Rosen, Esq.\n     Phillip Kim, Esq.\n     The Rosen Law Firm, P.A.\n     275 Madison Avenue, 40(th) Floor\n     New York, NY 10016\n     Tel: (212) 686-1060\n     Toll Free: (866) 767-3653\n     Fax: (212) 202-3827\n     case@rosenlegal.com (mailto:case@rosenlegal.com)\n     www.rosenlegal.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4680027-1&h=2029784092&u=http%3A%2F%2Fwww.rosenlegal.com%2F&a=www.rosenlegal.com)\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-first-filed-by-the-rosen-law-firm-302761651.html\n(https://www.prnewswire.com/news-releases/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-first-filed-by-the-rosen-law-firm-302761651.html)\n\nSOURCE THE ROSEN LAW FIRM, P. A.\n\n\n\nPhoto: \nhttps://mma.prnewswire.com/media/2598258/THE_ROSEN_LAW_FIRM_P_A_Logo.jpg\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-05-04T20:27:00.09353466Z","server_sent_at_ms":1777926420093},"received_at":"2026-05-04T20:27:00.153Z","source_url":"https://www.prnewswire.com/news-releases/ibrx-investors-have-opportunity-to-lead-immunitybio-inc-securities-fraud-lawsuit-first-filed-by-the-rosen-law-firm-302761651.html"},"analysis":{"id":"14464","press_release_id":"19753","analysis_json":{"industry":{"label":"Pharmaceuticals, Biotechnology & Life Sciences","sector":"Health Care"},"redFlags":[],"eventType":"legal_litigation","narrative":"Rosen Law Firm issued a solicitation notice for ImmunityBio investors regarding a securities fraud class action covering the period from January 19, 2026 to March 24, 2026.\n\nThe firm is reminding shareholders of the May 26, 2026 lead plaintiff deadline and encouraging investors to contact them for potential compensation on a contingency basis.\n\nThis is a plaintiff-firm marketing communication rather than an issuer disclosure; no class has been certified yet.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation -- suppress."},"keyFigures":{},"quotedText":"","namedEntities":{"people":[{"name":"Laurence Rosen","role":"Founding Partner"},{"name":"Phillip Kim","role":"Attorney"}],"products":["Anktiva"],"companies":[{"name":"The Rosen Law Firm, P.A.","relationship":"plaintiff law firm"},{"name":"ImmunityBio, Inc.","ticker":"IBRX"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm shareholder solicitation issued by Rosen Law Firm. No new disclosure from the issuer; no certified class, no settlement. Boilerplate lead-plaintiff-deadline reminder."},"tickerRelevance":{"others":[],"primary":"IBRX"},"globalImportance":15,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Rosen Law Firm issued a solicitation notice for ImmunityBio investors regarding a securities fraud class action covering the period from January 19, 2026 to March 24, 2026.\n\nThe firm is reminding shareholders of the May 26, 2026 lead plaintiff deadline and encouraging investors to contact them for potential compensation on a contingency basis.\n\nThis is a plaintiff-firm marketing communication rather than an issuer disclosure; no class has been certified yet.","key_figures":{},"named_entities":{"people":[{"name":"Laurence Rosen","role":"Founding Partner"},{"name":"Phillip Kim","role":"Attorney"}],"products":["Anktiva"],"companies":[{"name":"The Rosen Law Firm, P.A.","relationship":"plaintiff law firm"},{"name":"ImmunityBio, Inc.","ticker":"IBRX"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:a2703c5a1b5285fe","schema_hash":"sha256:1f8af1196c7db48c","created_at":"2026-05-04T21:18:16.101Z","global_importance":15,"audience_relevance":10,"importance_components":{"tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":44707,"modelName":"glm-4.7"}}